Physician profile
Ben Marsan
NPI 1518977479
$35,799.91
in general payments reported to CMS, 2019-2025
23 companies · $13K in 2025
The $13K reported for 2025 was more than what 92% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $61.02 · 2021: $286 · 2022: $435 · 2023: $8,927 · 2024: $13K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $32K · Food and Beverage: $2,534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $31,544.44 |
| Food and Beverage | $2,534.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $31,653.72 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Endologix LLC | $1,069.13 | 2023-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System, Endocross Device |
| Silk Road Medical, INC. | $840.85 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $503.97 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $408.60 | 2021-2025 | Enroute Transcarotid Neuroprotection System, Eluvia, Varithena Administration Pack |
| Cook Medical LLC | $298.77 | 2019-2025 | Zilver Ptx |
| E.R. Squibb & Sons, L.L.C. | $173.40 | 2019-2025 | Eliquis |
| Stryker Corporation | $141.81 | 2025 | Artix Mt, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $132.47 | 2021-2023 | Abre |
| Inari Medical, INC. | $126.82 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lemaitre Vascular, INC. | $109.93 | 2019-2024 | Artegraft Vascular Graft |
| Z-Medica, LLC | $44.32 | 2019 | |
| Medtronic Vascular, INC. | $41.65 | 2019 | |
| Abbott Laboratories | $37.73 | 2019 | |
| Cardiovascular Systems INC. | $37.25 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.78 | 2022-2025 | |
| Smith+Nephew, INC. | $35.13 | 2019-2025 | Renasys Touch |
| Covidien LP | $25.92 | 2019 | |
| Philips North America LLC | $23.30 | 2021 | |
| Haemonetics Corporation | $16.91 | 2023 | Teg6s Hemostasis System |
| Cordis US Corp. | $15.36 | 2024 | Radial 360 |
| Integra Lifesciences Corporation | $13.19 | 2021 | |
| Ethicon US, LLC | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Marsan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.